Literature DB >> 17107738

Brain cancer diagnosis and therapy with nanoplatforms.

Yong-Eun Lee Koo1, G Ramachandra Reddy, Mahaveer Bhojani, Randy Schneider, Martin A Philbert, Alnawaz Rehemtulla, Brian D Ross, Raoul Kopelman.   

Abstract

Treatment of brain cancer remains a challenge despite recent improvements in surgery and multimodal adjuvant therapy. Drug therapies of brain cancer have been particularly inefficient, due to the blood-brain barrier and the non-specificity of the potentially toxic drugs. The nanoparticle has emerged as a potential vector for brain delivery, able to overcome the problems of current strategies. Moreover, multi-functionality can be engineered into a single nanoplatform so that it can provide tumor-specific detection, treatment, and follow-up monitoring. Such multitasking is not possible with conventional technologies. This review describes recent advances in nanoparticle-based detection and therapy of brain cancer. The advantages of nanoparticle-based delivery and the types of nanoparticle systems under investigation are described, as well as their applications.

Entities:  

Mesh:

Year:  2006        PMID: 17107738     DOI: 10.1016/j.addr.2006.09.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  67 in total

1.  Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?

Authors:  Yu Cheng; Joseph D Meyers; Richard S Agnes; Tennyson L Doane; Malcolm E Kenney; Ann-Marie Broome; Clemens Burda; James P Basilion
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

2.  Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

Authors:  Forrest M Kievit; Omid Veiseh; Chen Fang; Narayan Bhattarai; Donghoon Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  ACS Nano       Date:  2010-08-24       Impact factor: 15.881

3.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

4.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

Review 5.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

Review 6.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 7.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

Review 8.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

Review 9.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.

Authors:  Omid Veiseh; Jonathan W Gunn; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

10.  Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness.

Authors:  Wei Tang; Hao Xu; Edwin J Park; Martin A Philbert; Raoul Kopelman
Journal:  Biochem Biophys Res Commun       Date:  2008-02-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.